09/24/2026
We are proud to be a Sponsor and Supporter of this event.
Did You Know???
Sickle cell disease (SCD) is an inherited blood disorder affecting hemoglobin, the protein responsible for carrying oxygen throughout the body. Despite being the first molecular disease ever identified, patients with SCD frequently navigate severe systemic bias and medical stigma that directly compromise their clinical care.
🧬 Key Facts About Sickle Cell Disease
• The Cause: A genetic mutation causes red blood cells to become stiff, sticky, and shaped like a crescent or "sickle" (rather than round and flexible). These cells clump together and block blood flow, starving tissues of oxygen.
• The Population: Globally, it affects millions, with a heavy concentration in sub-Saharan Africa. In the United States, it affects approximately 100,000 people, predominantly those of African descent (about 1 in 13 African Americans carry the trait) and Hispanic Americans.
• Primary Symptoms: The hallmark of SCD is a vaso-occlusive crisis (VOC), which causes sudden, excruciating, and unpredictable pain episodes. Over time, chronic tissue starvation can lead to stroke, organ damage, severe anemia, and a shortened life expectancy.
• Treatment Options: Traditional therapies include Hydroxyurea (to prevent sickling), L-glutamine, regular blood transfusions, and specialized pain management. While bone marrow transplants can help the disease, they carry high risks. Advanced gene therapies have emerged as groundbreaking, transformative treatment options, but carry lots of risk and come with a $2.5 million dollar price.
🛑 Bias and Stigma in Healthcare
Because of historical inequities, institutional racism, and a lack of widespread medical education, SCD patients experience distinct forms of clinical bias:
1. The "Drug-Seeking" Label
2. Delays in Emergency Care
3. Funding and Research Inequities
4. Provider Knowledge Gaps
We can all make a difference by supporting those impacted by this horrible disease.
